.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Global Expert Perspectives on Treatment Strategies in Neuroendocrine Tumors

EP. 1: The Underlying Biology and Prevalence of NETs

January 7th 2019

EP. 2: Accurately Diagnosing NETs

January 7th 2019

EP. 3: Classifying and Treating NETs

January 7th 2019

EP. 4: Recognizing the Symptoms of NETs

January 7th 2019

EP. 5: Therapies for Controlling Symptoms of NETs

January 7th 2019

EP. 6: Surgical Considerations for Patients With NETs

January 7th 2019

EP. 7: Somatostatin Analogs in the Treatment of NETs

January 7th 2019

EP. 8: Targeted Therapies for the Treatment of NETs

January 7th 2019

EP. 9: Peptide Receptor Radionuclide Therapy for NETs

January 7th 2019

EP. 10: Somatostatin Analogs and PRRT: Treatment Considerations

January 7th 2019

EP. 11: Chemotherapy for NETs: Temozolomide

January 7th 2019

EP. 12: Novel Therapies Emerging for the Treatment of NETs

January 7th 2019

EP. 13: Future Outlook: Improving the Management of NETs

January 7th 2019